|
GOSR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.386600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.322400E-01 |
| Normal-vs-Stage2 |
8.870400E-01 |
| Normal-vs-Stage3 |
3.404400E-01 |
| Normal-vs-Stage4 |
3.447000E-01 |
| Stage1-vs-Stage2 |
7.565600E-01 |
| Stage1-vs-Stage3 |
7.594800E-01 |
| Stage1-vs-Stage4 |
7.598000E-01 |
| Stage2-vs-Stage3 |
5.871800E-01 |
| Stage2-vs-Stage4 |
5.755200E-01 |
| Stage3-vs-Stage4 |
9.066200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.442200E-01 |
| Normal-vs-AfricanAmerican |
1.073570E-01 |
| Normal-vs-Asian |
4.701500E-02 |
| Caucasian-vs-AfricanAmerican |
1.630980E-01 |
| Caucasian-vs-Asian |
4.549600E-01 |
| AfricanAmerican-vs-Asian |
6.768400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.048400E-01 |
| Normal-vs-Female |
3.552800E-01 |
| Male-vs-Female |
6.887800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.901900E-02 |
| Normal-vs-Extreme_Weight |
1.432180E-01 |
| Normal-vs-Obese |
8.221000E-01 |
| Normal-vs-Extreme_Obese |
9.734600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.336000E-01 |
| Normal_Weight-vs-Obese |
5.482400E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.907400E-01 |
| Extreme_Weight-vs-Obese |
1.819040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.535600E-01 |
| Obese-vs-Extreme_Obese |
9.542800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.195400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.759800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.937700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.074000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.731400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.884200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.128200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.904700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.233800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.005400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.993000E-01 |
| Normal-VS-Type2 PRCC |
2.173800E-02 |
| Normal-VS-KIRP CIMP |
5.521800E-01 |
| Normal-VS-Unclassified PRCC |
5.346400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.002000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.130000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.673400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.384250E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.302200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.205800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.676020E-02 |
| Normal-vs-N1 |
8.364000E-01 |
| Normal-vs-N2 |
1.631550E-02 |
| N0-vs-N1 |
9.105800E-02 |
| N0-vs-N2 |
6.769200E-01 |
| N1-vs-N2 |
2.804800E-01 |
|
|
